EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Shiga Toxin 1a Blunts Shiga Toxin 2a-pathogenic Effects in Blood

Elisa Varrone, Luciano Consagra, Giorgia Rossi, Domenica Carnicelli, Paola Paterini, Barbara Brunetti, Francesca Ricci, Pier Luigi Tazzari, Gianluca Storci, Massimiliano Bonafè, Gianluigi Ardissino, Maurizio Brigotti

Thrombosis and Haemostasis · 2026-11 · 126 (11) · 1133-1142

DOI: 10.1055/a-2805-9903 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thrombosis and Haemostasis, online erschienen am 24.02.2026. Verfasst von Elisa Varrone und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Shiga Toxin 2, Shiga Toxin 1, Hemolytic-Uremic Syndrome, Shiga-Toxigenic Escherichia coli. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università di Bologna, Progetto ALICE Associazione per la lotta alla SEU - ETS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Once released into human blood, Shiga toxins (Stx) interact with platelets and leukocytes, stimulating them to form aggregates and to release pathogenic extracellular vesicles (EV) containing Stx. These EV are considered the trigger driving the transition from bloody diarrhea to the life-threatening hemolytic uremic syndrome (HUS) during human infections by Stx-producing Escherichia coli (STEC). In children, HUS is characterized by hemolytic anemia, thrombocytopenia, and acute renal failure. The risk of any STEC-infected patient of developing HUS varies significantly depending on the Stx type produced by the bacteria, i.e., it is negligible for Shiga toxin 1 (Stx1), relevant for Shiga toxin 2 (Stx2), and considerably reduced when both toxins are present. To mimic what happens in the bloodstream of patients, human blood was challenged with Stx2a, Stx1a, or both toxins, and the formation of leukocyte/platelet aggregates was evaluated by direct-flow cytometric analysis. Pathogenic blood cell-derived EV were then isolated, their number and size determined by nanoparticle tracking analysis, and their proteins characterized by capillary Western blotting. We found that the presence of Stx1a during Stx2a challenge significantly reduced the formation of pathogenic EV, particularly the large (>300 nm) EV population causing HUS development. Notably, the amount of Stx2a significantly decreased in Stx1a + Stx2a-triggered EV with respect to Stx2a-induced EV. Our findings suggest that in STEC-infected children the presence of Stx1 in association with Stx2 reduces the risk of developing HUS by lowering the release of Stx2-containing blood cell-derived EV which are considered the main culprits for HUS onset.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Shiga Toxin 2Shiga Toxin 1Hemolytic-Uremic SyndromeShiga-Toxigenic Escherichia coliEscherichia coli InfectionsHumansBlood PlateletsLeukocytesPlatelet AggregationFlow Cytometry

Substanzen

Shiga Toxin 2Shiga Toxin 1

Autor:innen und Institutionen

  • Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.
  • Center for Applied Biomedical Research-CRBA, University of Bologna, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Department of Veterinary Medical Sciences (DIMEVET), University of Bologna, Ozzano dell'Emilia, Bologna, Italy.
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Center for HUS Control, Prevention and Management, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Förderung

  • Università di Bologna
  • Progetto ALICE Associazione per la lotta alla SEU - ETS

Zitieren

APA

Varrone, E., Consagra, L., Rossi, G., Carnicelli, D., Paterini, P., Brunetti, B., Ricci, F., Tazzari, P. L., Storci, G., Bonafè, M., Ardissino, G., & Brigotti, M. (2026). Shiga Toxin 1a Blunts Shiga Toxin 2a-pathogenic Effects in Blood. Thrombosis and Haemostasis, 126(11), 1133-1142. https://doi.org/10.1055/a-2805-9903

Vancouver

Varrone E, Consagra L, Rossi G, Carnicelli D, Paterini P, Brunetti B, et al. Shiga Toxin 1a Blunts Shiga Toxin 2a-pathogenic Effects in Blood. Thrombosis and Haemostasis. 2026;126(11):1133-1142. doi:10.1055/a-2805-9903

BibTeX
@article{Varrone2026,
  author = {Varrone, Elisa and Consagra, Luciano and Rossi, Giorgia and Carnicelli, Domenica and Paterini, Paola and Brunetti, Barbara and Ricci, Francesca and Tazzari, Pier Luigi and Storci, Gianluca and Bonafè, Massimiliano and Ardissino, Gianluigi and Brigotti, Maurizio},
  title = {Shiga Toxin 1a Blunts Shiga Toxin 2a-pathogenic Effects in Blood},
  journal = {Thrombosis and Haemostasis},
  year = {2026},
  volume = {126},
  number = {11},
  pages = {1133--1142},
  doi = {10.1055/a-2805-9903}
}
Kostenlos starten →